ArtVentive Medical Group, Inc. (OTCBB: AVTD) announced today that it is executing its planned expansion of its European distributor network to provide product training and support to distributors in 15 countries. This expansion will add significantly to the Company’s geographic reach throughout the European markets in addition to Australia and New Zealand.

“We expect the growth of the ArtVentive distribution base to take the Company one step closer to achieving its global corporate mandate to impact medical costs through the implementation of the ArtVentive EOS™ system,” stated Jim Graham, Chief Executive Officer. “We are very pleased with the interest we have received from the medical community and distributors globally and look forward to expanding our corporate reach through strong partnerships in each region.”

About ArtVentive Medical Group, Inc.

ArtVentive Medical Group, Inc., with corporate headquarters in Carlsbad, California, is an innovative, multi-faceted medical device company focused on developing, manufacturing and marketing globally a family of devices featuring the ArtVentive EOS™ system.

The ArtVentive EOS™ is catheter-based, self-expandable and facilitates permanent or temporary occlusion of peripheral body lumens, cavities occurring within the body’s vascular system and organ network. The ArtVentive EOS™ is designed to serve as a safe and reliable alternative to major surgery in certain cases. This technological innovation brings current interventional, image-guided techniques to a new level of sophistication, with the potential to resolve significant, unaddressed health issues.

The ArtVentive EOS™ serves as a proprietary technological platform for several major clinical areas, including peripheral, neurological vascular disorders, women’s health (minimally invasive contraceptive and birth control) and interventional cardiology, pulmonary and interventional oncology procedures.

More information about ArtVentive Medical Group, Inc. can be found at www.artventivemedical.com.

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company’s current expectations, projections and beliefs concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance. Forward-looking statements involve uncertainties, risks, assumptions and contingencies, many of which are outside the Company’s control, thus, actual results could differ materially from those described in or implied by any forward-looking statement. All forward-looking statements are based on currently available information and speak only as of the date on which they are made. The Company assumes no obligation to update regarding any forward-looking statement made in this news release that becomes untrue because of subsequent events, new information or otherwise, except to the extent it is required to do so in connection with the Company’s ongoing requirements under federal securities laws. For a further discussion of factors that could cause the Company’s future results to differ materially from any forward-looking statements, see the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and other periodic reports filed by the Company from time to time with the Securities and Exchange Commission.